3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Neoplasm Metastasis
7
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Glioblastoma
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Hereditary Sensory and Autonomic Neuropathies
2
Tongue Neoplasms
1
Thymoma
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Laryngeal Neoplasms
1
Hypoxia
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Gliosarcoma
1
Interventions
ulixertinib
1
tislelizumab
1
talazoparib
1
serabelisib
1
sapanisertib
1
pembrolizumab
1
olaparib
1
mirdametinib
1
lenvatinib
1
erdafitinib
1
crenigacestat
1
atezolizumab
1
Ramucirumab
1
Paclitaxel
1
PM 01183
1
Injections
1
IFL protocol
1
Gemcitabine
1
Bosentan
1
BID protein, human
1
Appointments and Schedules
1
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumor
×
NVP-BKM120
×
Clear all
No trials found.